Molecular Diagnostics Market By Reports And Data
                     Molecular Diagnostics Market to 
Reach USD 13.81 Billion By 2026
www.reportsanddat
a.com
       Market  Summary
Rising number of cancer cases, growing incidence of infectious 
diseases, strong government funding for medical science and the 
increasing application of patient-specific treatments are key 
factors contributing to high CAGR of Molecular Diagnostics during 
the forecast period.
Market Size – USD 7.28 Billion in 2018, Market Growth - CAGR of 
8.2%, Market Trends – impressive growth in colorectal cancer 
molecular diagnostics market
According to the current analysis of Reports and Data, the global 
Molecular Diagnostics market was valued at USD 7.28 Billion in 
2018 and is expected to reach USD 13.81 Billion by year 2026, at a 
CAGR of 8.2%. 
            M  a Orkuetr  S Aumpmparroyach
The increasing efficiency of clinical trials, growing incidence of infectious and neurological diseases, and 
technological advancements in molecular pathology are major driving factors being the growth of the market. 
The increasing government aid for research and establishment of advanced testing facilities is also supporting 
the growth of the market.
The developing economies of India and China face some challenges in the form of the lack of a well-built 
procedural system for approvals, which hinders the growth of the molecular diagnostics market. Moreover, a 
shortage of skilled medical professionals is also limiting the growth of the market in many countries.
Request for a sample of this research report @ https://www.reportsanddata.com/sample-enquiry-form/945
       M   a r kOeut  Sru Ampmparyoach
Key Players Are Abbott, Roche Diagnostics, QIAGEN, Danaher, Hologic, Becton, Siemens Healthcare GmbH, 
Bio-Rad Laboratories, Dickinson and Co., Cepheid
For the purpose of this report, Reports and Data has segmented the Molecular Diagnostics market on the 
basis of product and service, technology, application, end use, and region:
Product and Service (Revenue, USD Million; 2016–2026)
• Reagents and Kits
• Instruments
• Services and Software
Technology (Revenue, USD Million; 2016–2026)
• Polymerase Chain Reaction (PCR) 
• Isothermal Nucleic Acid Amplification Technology (INAAT) 
• DNA Sequencing & Next-Generation Sequencing (NGS) 
• in Situ Hybridization 
• DNA Microarray 
• Other Technologies
       M   a r kOeut  Sru Ampmparyoach
Application (Revenue, USD Million; 2016–2026)
• Infectious Diseases
• Oncology
• Genetic Tests
• Others
End Use (Revenue, USD Million; 2016–2026)
• Hospital and Academic Laboratories
• Reference Laboratories
• Others
Regional Outlook (Revenue in USD Million; 2016–2026)
• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Latin America
Order Now: https://www.reportsanddata.com/checkout-form/945
About Us
   A  b  oOuutr U Aspproach
Reports and Data is a market research and consulting company that provides syndicated research 
reports, customized research reports, and consulting services. Our solutions purely focus on your 
purpose to locate, target and analyze consumer behavior shifts across demographics, across industries 
and help client’s make a smarter business decision. We offer market intelligence studies ensuring 
relevant and fact-based research across a multiple industries including Healthcare, Technology, 
Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are 
aware about the latest trends existent in the market. Reports and Data has a strong base of 
experienced analysts from varied areas of expertise.
Contact Us:
John Watson
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]